DIN 02162423 — NAPROSYN 500 MG
NAPROSYN is a tablet (delayed-release) of Naproxen marketed by SEARCHLIGHT PHARMA INC. The full Naproxen monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02162423
- Brand name
- NAPROSYN
- Active ingredient
- Naproxen
- Strength
- 500 MG
- Dosage form
- TABLET (DELAYED-RELEASE)
- Route
- ORAL
- Manufacturer
- SEARCHLIGHT PHARMA INC
- Health Canada status
- MARKETED
- Drug class
- Non-steroidal anti-inflammatory drug (NSAID)
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.
Other Naproxen products
| DIN | Brand | Strength | Form | Manufacturer | Status |
|---|---|---|---|---|---|
| 02436337 | ALEVE BACK AND BODY PAIN | 220 MG | CAPSULE | BAYER INC | MARKETED |
| 02301733 | ALEVE CAPLETS | 220 MG | TABLET | BAYER INC | MARKETED |
| 02361795 | ALEVE LIQUID GELS | 220 MG | CAPSULE | BAYER INC | MARKETED |
| 02162725 | ANAPROX | 275 MG | TABLET | SEARCHLIGHT PHARMA INC | MARKETED |
| 02162717 | ANAPROX DS | 550 MG | TABLET | SEARCHLIGHT PHARMA INC | MARKETED |
| 00522678 | APO NAPROXEN TAB 125MG | 125 MG | TABLET | APOTEX INC | DORMANT |
| 00784354 | APO-NAPRO-NA | 275 MG | TABLET | APOTEX INC | MARKETED |
| 01940309 | APO-NAPRO-NA DS | 550 MG | TABLET | APOTEX INC | MARKETED |
| 00522651 | APO-NAPROXEN | 250 MG | TABLET | APOTEX INC | MARKETED |
| 00600806 | APO-NAPROXEN | 375 MG | TABLET | APOTEX INC | MARKETED |
| 00592277 | APO-NAPROXEN | 500 MG | TABLET | APOTEX INC | MARKETED |
| 02246700 | APO-NAPROXEN EC | 375 MG | TABLET (ENTERIC-COATED) | APOTEX INC | MARKETED |
| 02246701 | APO-NAPROXEN EC | 500 MG | TABLET (ENTERIC-COATED) | APOTEX INC | MARKETED |
| 02246699 | APO-NAPROXEN EC TABLETS | 250 MG | TABLET (ENTERIC-COATED) | APOTEX INC | MARKETED |
| 02177072 | APO-NAPROXEN SR TABLETS 750MG | 750 MG | TABLET (EXTENDED-RELEASE) | APOTEX INC | DORMANT |
| 02372991 | MAXIDOL LIQUID GELS | 220 MG | CAPSULE | BAYER INC | MARKETED |
| 02162466 | NAPROSYN | 750 MG | TABLET (EXTENDED-RELEASE) | SEARCHLIGHT PHARMA INC | MARKETED |
| 02362430 | NAPROXEN | 220 MG | TABLET | PHARMASCIENCE INC | MARKETED |
| 02418835 | NAPROXEN CAPSULES 200 MG | 200 MG | CAPSULE | CATALENT ONTARIO LIMITED | DORMANT |
| 02396009 | NAPROXEN MENSTRUAL PAIN RELIEF | 220 MG | TABLET | PHARMASCIENCE INC | MARKETED |
| 02385007 | NAPROXEN SODIUM TABLETS | 220 MG | TABLET | APOTEX INC | DORMANT |
| 00887056 | NAPROXEN-NA | 275 MG | TABLET | PRO DOC LIMITEE | MARKETED |
| 02153386 | NAPROXEN-NA DF | 550 MG | TABLET | PRO DOC LIMITEE | MARKETED |
| 02162431 | PEDIAPHARM NAPROXEN SUSPENSION | 25 MG | SUSPENSION | MEDEXUS PHARMACEUTICALS INC. | MARKETED |
| 02310953 | PRO-NAPROXEN EC | 500 MG | TABLET (ENTERIC-COATED) | PRO DOC LIMITEE | MARKETED |
| 00565350 | TEVA-NAPROXEN | 250 MG | TABLET | TEVA CANADA LIMITED | MARKETED |
| 00627097 | TEVA-NAPROXEN | 375 MG | TABLET | TEVA CANADA LIMITED | MARKETED |
| 00589861 | TEVA-NAPROXEN | 500 MG | TABLET | TEVA CANADA LIMITED | MARKETED |
| 02243312 | TEVA-NAPROXEN EC | 250 MG | TABLET (ENTERIC-COATED) | TEVA CANADA LIMITED | MARKETED |
| 02243313 | TEVA-NAPROXEN EC | 375 MG | TABLET (ENTERIC-COATED) | TEVA CANADA LIMITED | MARKETED |
| 02243314 | TEVA-NAPROXEN EC | 500 MG | TABLET (ENTERIC-COATED) | TEVA CANADA LIMITED | MARKETED |
| 00778389 | TEVA-NAPROXEN SODIUM | 275 MG | TABLET | TEVA CANADA LIMITED | MARKETED |
| 02026600 | TEVA-NAPROXEN SODIUM DS | 550 MG | TABLET | TEVA CANADA LIMITED | MARKETED |